• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Could New Labor Management Guidelines be Doing More Harm than Good?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Curves derived from the Consortium on Safe Labor data differ from the previous Friedman curve
    • Active labor began at 6 cm dilation in multiparous and nulliparous patients and not 4 cm as per the Friedman curve
  • 2014, ACOG/SMFM/Obstetric Care Consensus statement proposed that
    • Cesarean section rate could be lowered by not calling arrest of dilation at < 6 cm
    • In the 2nd stage, multiparas could push for at least 2 hours and nulliparas for at least 3 hours
  • Rosenbloom et al. (AJOG, 2017) sought to determine whether
    • Rates of arrest of dilation disorders have decreased thereby reducing the rate of cesarean delivery (CD) in low-risk women at term
    • Pushing duration prior to diagnosis of arrest of descent has increased, likewise reducing the rate of CD

METHODS:

  • Secondary analysis of prospective cohort study
  • All low risk patients presenting at ≥ 37 weeks’ gestation (2010 – 2014) for either spontaneous or induced labor
  • Low risk was defined as patients like those in the Consortium on Safe Labor cohort
  • Exclusion criteria
    • Previous CD, multiple gestation, nonvertex presentation, fetal anomalies, IUFD
    • Women presenting for scheduled CD
  • Primary Outcomes
    • Rates of CD
    • Indications for CD
    • Average dilation at CD for arrest

RESULTS:

  • 7845 eligible patients.
  • There was no difference between 2010 and 2014 in CD rate (15.8% vs 17.7%)
  • There was no difference between 2010 and 2014 in the median cervical dilation (5.5 cm vs 6.0 cm) at the time of CD for arrest of dilation
    • There was an increase in the time spent at last dilation from 3.8h in 2010 to 5.2h in 2014 (p-trend 0.02)
  • There was no difference between 2010 and 2014 in the frequency of patients diagnosed with arrest of dilation at <6 cm (p-trend 0.56)
    • The median time spent at the last cervical dilation was 4.0h in 2010 and 6.7h in 2014 (p-trend 0.046)
  • There were 206 CDs for arrest of descent
    • The median pushing time increased in multiparous patients from 1.1h in 2010 to 3.4h in 2014 (p-trend 0.009)
    • The median pushing time increased in nulliparous patients from 2.7h in 2010 to 3.8h in 2014 (p-trend 0.09)
  • There were increasing adverse neonatal and maternal outcomes (p<0.001 for each)
    • The adjusted odds ratio (OR) for adverse maternal outcome for 2014 compared to 2010 was 1.66 (95%CI 1.27-2.17)
    • The aOR for adverse neonatal outcome in 2014 compared to 2010 was 1.80 (95%CI 1.36-2.36)
  • Majority of arrest of dilation occurred in women undergoing induction of labor

CONCLUSION:

  • Strengths of the study included prospective data collection
  • Observational design so results reflect association and not causation
  • Findings differ from previous study but authors point out the current study had a larger sample number over a longer period and patients had substantially higher BMI
  • Moving to the new ‘6cm curve’ did not reduce the primary CD rate and there has been an increase in maternal and neonatal morbidity
  • A randomized controlled trial is needed

Learn More – Primary Sources:

New Labor Management Guidelines and Changes in Cesarean Delivery Patterns

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Can Evidence Based Interventions Reduce C-section Complications?
Induction to Prevent Stillbirths for Age 35 and Older: Impact on Cesarean Rates?
Practical info on evidence based medicine for your women's healthcare practice
Labor Induction and an Unripe Cervix: Does it Result in More C-sections?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site